Bioequivalence Study of Palbociclib 125 mg Capsules of Iclos vs. Ibrance (Palbociclib) Capsules 125 mg

NCT06331715 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Palbociclib 125mg

Sponsor

Megalabs